Our New JULY appointed BMS Board Member, Derica W. Rice CVS Health, President CAREMARK PBM

Discussion in 'Bristol-Myers Squibb' started by anonymous, Nov 5, 2020 at 12:33 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    This is a FREE country last we knew. My constitutional amendment rights are still there we might hope.

    So, let's simply start with some links for your reading pleasure during a pandemic with more Americans hurting without jobs and many human beings of all race, color and creed needing help from programs like Medicaid.

    As you are aware the most RECENT JOB...Derica W. Rice had was listed AFTER our Press Release July 30, 2020 mentioned Mr. Rice's twenty-five plus years at Lilly in various FINANCE positions, including CFO. That position if you didn't catch it was with CVS Health as an EVP, and PRESIDENT of CVS Caremark PBM business across the United States of America. Let's go from there. No imagination required.

    Bristol Myers Squibb Board Elects Two New Independent Directors

    Derica W Rice, CVS Health Corp: Profile and Biography

    https://www.linkedin.com/in/derica-rice/

    Compensation Information for Derica W. Rice, Executive Vice President and President -CVS Caremark of CVS HEALTH CORP | Salary.com

    Aetna whistleblower accuses CVS Health's Caremark of fraud in Medicare Part D drug prices

    Omnicare and parent company CVS Health charged with prescription drug fraud

    Fraud Spotlight: CVS/Caremark Network Agreement - Advize Health

    CVS Caremark accused of $1 billion in Medicare drug fraud | JustCare

    Whistleblower files lawsuit against CVS Caremark for falsifying drug prices | Anti Corruption Digest

    Feds said to be investigating largest Medicaid provider in the U.S. - Ohio Capital Journal
     

  2. anonymous

    anonymous Guest

    A few more links that speak the very large amount of money in states like Ohio's Medicaid budget to again, help people of all race, color and creed,

    These Senators Received The Biggest Checks From CVS, Humana And Other Drug Middlemen Testifying Tuesday

    (Pay attention to company and INDIVIDUAL donations to people like Sen. Rob Portman, OH.)

    Community pharmacy group says CVS, other bigs are unfairly steering patients - Ohio Capital Journal

    Ohio pharmacists say some Medicaid payments shrinking due to CVS Caremark rates
     
  3. anonymous

    anonymous Guest

    Metcalfe just got the axe, another CVS person.
     
  4. anonymous

    anonymous Guest

    Here are some more links that reinforce what you likely already know across this country about CVS Caremark PBM under Derica W. Rice's "leadership". The incestuous corruption in the health care industry we've respected in the ranks runs so deep. It is now reached pathetic depths. And this same person in a Fortune article, self authored, (published September 30, 2015 9:35 AM EDT) speaks of " For me, my true calling is here -- ----- helping patients live longer, healthier lives. I can’t think of a more noble pursuit than that." (link attached).

    Well, we need to rewrite Derica W. Rice's Eulogy to reflect the fact that actions that harm others for power and financial gain, whether you happen to work for a large health care company or not, nullifies that "good" you lavish upon yourself in an article written by "yourself". You are not the judge of you. Your integrity is massively in question for all things you've done to affect others. That's your true, honest, complete legacy.

    But you know you are guilty of relatively sophisticated, convoluted, opaque means and ways to financially extract millions of U.S. dollars out of various states and the very people who serve them in smaller, independent pharmacies or the poor patients who need real assistance. Hellbent to destroy. To remorselessly dominate. To co-opt by any Machiavellian means. That's your accounting skills at work in noble pursuit of what, you say?

    Big fight over drug pricing with implications for Minnesota heads to the Supreme Court - Minnesota Reformer

    Big fight over drug pricing heads to the Supreme Court - Virginia Mercury

    Audit: PBMs paying pharmacies differently; CVS Caremark says that's normal business

    Dispatch analysis: State’s attempt to curb drug middlemen mostly futile – Side Effects

    State report: Pharmacy middlemen reap millions from tax-funded Medicaid – Side Effects

    This CFO’s key to success: Stop pursuing perfection
     
  5. anonymous

    anonymous Guest

    Now here (above) is someone who knows how to read the writing on the executive's walls. "Closer to home....lmao" Some of us know for fact that was not the reason she left CVS Health for lucky Bristol-Myers Squibb.

    The trend is in, BRISTOL-MYERS SQUIBB led by the amazing talent evaluator himself, Giovanni "C", is learning how to up it's game like CVS Health "led" by Larry J. Merlo. CVS Health, the epitome of abuse of it's professional pharmacy workforce and all the other hard working CVS employees that land large Larry more than even he can consume in a 1000 gluttonous lifetimes.

    There's that noble calling you espouse Derica. It was right in front of your "accounting" eyes.
     
  6. anonymous

    anonymous Guest

    Again, first Amendment rights, free speech and freedom to voice an opinion in case these vicious, powerful, wealthy, honorable, kind, loving people send lawyers. But, really, there is nothing they can take from you that you haven't already given them by living lives of weak, capitulated desperation. That's most of you in BMS land.

    Here's how 'apparently' corrupt this "genius" accountant is and how he could CARE LESS how "long and healthy they live their lives". Unless, he can extract every available U.S. dollar from each and every last one of them
    that could be family, the people you pray for that really don't have much, friends in rural parts of this country, people with bad breaks, minorities pushed aside in a cycle of poverty, etc. He could give a shit less. That is his eulogy, his legacy.

    Two GREAT QUOTES from real health care professionals. PHARMACISTS to respect the profession and the people that SERVE:

    But Doug Hoey, CEO of the National Pharmacists Association, said that in the two years leading up to the coronavirus pandemic 2,000 — or 4 percent — of all U.S. pharmacies have closed. In small-town and rural communities , some of the closures have created pharmacy deserts, where people lost their closest, most frequent point of contact with the health care system.

    The problem is only growing, Hoey said. The big three PBMs control more than 70 percent of that marketplace and a recent wave of blockbuster mergers with insurance companies have left CVS Health the fifth-largest corporation in the country, ...
    “Imagine if the New York Yankees had the power to make their own rules and supply the umpires for the game,” Hoey said.

    Antonio Ciaccia, lobbyist for the Ohio Pharmacists Association, describes what CVS did this way:
    “The state slapped their hand and said, 'Stop taking money from us this way.' They say, 'OK, we’ll take it another way.'”

     
  7. anonymous

    anonymous Guest

    So, let's ask this newly added Bristol-Myers Squibb Board Member a few easy questions,

    A few questions posed to Derica W. Rice, "financial genius", who choose the hardship route like an account at the NIH. Yes, Derica choose, as he has self proclaimed his nobility, to suffer greatly working for millions at a large, coincidentally health care company. Then, he rode his professional 'horse' to an even higher moral calling working for an ugly little U.S. penny at infamous, CVS Health as PRESIDENT of CVS Caremark.

    And Derica has been ADDED to the Bristol-Myers Squibb Board of DIRECTORS during a massive social awaking. A period of social conscious and caring for all peoples, all types, everywhere, all the time. So, we know Derica will, with his immense ethical and moral strength DO the RIGHT thing. Always. He will SPEAK UP on ALL topics of inequality and moral failing at Bristol-Myers Squibb. We now have a new savior to lead us to honest milk & honey.

    So, we are certain he will get these questions brought before his holy, "accounting" eyes. We know in faith, he will answer them with purity and completeness.

    1) As you were looking to move into (i.e. PRIOR to) the President's position to lead CVS Caremark,
    • WHAT ACCOUNTING IRREGULARITIES DID YOU TAKE ACCOUNT OF?
    • What did you think of the CVS Caremark's business "behavior" in states like MN, AR, OH, etc.?
    • What did you want to ethically and morally change immediately if selected as President, Caremark?
    2) Once in the position as President, CVS Caremark,
    • Share all the accounting practices dealing with "PRICE SPREAD" that Caremark was mastering?
    • What was your noble and moral opinion of these business pricing and accounting practices?
    • When did you decide to continue and expand those "price spread" practices?
    • What did you say to your leadership team that gave them clear moral and ethical direction regarding all matters germane to how to profit from both federal and specifically, state Medicaid programs?
    3) Share with all of us hard working people at Bristol-Myers Squibb,
    • Specifically, how have you already or will share your immense expertise and importantly, business "secrets" regarding how an ETHICAL pharmaceutical company like Bristol-Myers Squibb can leverage your ultimate, inside knowledge?
    • What Pharmacy Benefits Manager "know how", "roadmaps", evolutionary knowledge from your CVS Caremark tenure as their President with your share with "us"?
    • And, most importantly, what CVS Caremark business "MAGIC" will you create for us here at Bristol-Myers Squibb?
      • By magic, since you asked..., we mean, "business maneuvers, machinations and semi-transparent (opaque as needed)" accounting principals and practice that ultimately, result in superior income streams?
     
  8. anonymous

    anonymous Guest

    Derica W. Rice,

    You are charged with harming patients, states and pharmacies across this country. This is your legacy. It is part of your full and truthful eulogy.

    No matter the legal outcome, you know that truth. No matter your rationalizations and rebuttals, you live with that truth. You have played a major role in harming this nation. Now you sit on our Bristol-Myers Squibb Board. Let's see how you practice and perfect moral and social relativism at Bristol-Myers Squibb?


    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>


    PBM business practices have caused widespread harm ............................................
    5 1. Harm to pharmacies.................................
    5 2. Harm to patients ......................................
    9 3. Harm to States .......................................

    https://www.supremecourt.gov/DocketPDF/18/18-540/134605/20200302130544620_18-540tsacCalifornia.pdf

    APRIL 24, 2020

    Says, ‘it’s time for states to have the tools they need to ensure that prescription drug prices are affordable’

    LITTLE ROCK – Arkansas Attorney General Leslie Rutledge today filed a reply brief with the United States Supreme Court in Arkansas’s pharmacy benefit manager (PBM) case, Rutledge v. Pharmaceutical Care Management Association. In this case, Rutledge seeks to protect rural Arkansas’s small businesses and save community pharmacies from abusive PBM payment practices. The Supreme Court was scheduled to hear oral arguments in late-April but arguments were postponed until the fall as a result of COVID-19.

    “Our case to protect Arkansans and local pharmacies has such broad-based support that we are looking forward to the opportunity to present our case before the highest Court,” said Attorney General Rutledge. “In the midst of the economic hardship caused by the pandemic, it’s time for states to have the tools they need to ensure that prescription drug prices are affordable while protecting their frontline healthcare providers.”

    In 2015, the Arkansas General Assembly enacted Act 900 to regulate PBM—the drug middlemen that reimburse pharmacists for prescription drugs. Before Act 900’s enactment, PBMs regularly paid pharmacies less than it costs pharmacies to acquire generic drugs while pocketing a hefty profit. That abusive market practice had caused more than 16 percent of rural pharmacies nationwide to close in recent years.

    Rutledge’s petition was granted by the U.S. Supreme Court January 2019. Rutledge’s briefs have been supported by the U.S. Solicitor General and a bipartisan, 45-state coalition led by California.
     
  9. anonymous

    anonymous Guest

    Didn't realize Alex Jones frequented this forum.
     
  10. anonymous

    anonymous Guest

    Here is as "short list" of what this U.S. citizen, Derica W. Rice, our newly elected Board Member, did leading CVS Caremark as their President to other U.S. citizens. Things he led as President of said organization in pursuit of competitive dominance, wealth and ultimately, health care power over people, the pharmacy profession and States:

    1. Steered patients to CVS Caremark, CVS Health interests
    2. Abuse of negotiating power in forms adversely affecting underserved patients, pharmacies & pharmacists and states
    3. Perfected "retail spread" pricing that created unfair, immoral and unethical competitive advantage
    4. Curtailed access to quality health care in INNER CITY, rural and underserved areas of the United States
    5. Effectively RAISED drug prices as CVS Caremark claims like politicians, they are lowering them
      1. PBM rebates have forced companies like ours, to raise our manufacturing price on drugs like Eliquis each January to keep our mighty profits up. (We aren't going to "lose" either.)
      2. Those PBM rebates are not fully passed on the consumer, the patients we all SERVE
      3. CVS Caremark loves increased drug prices because you don't have to be an accounting genius regarding increased rebates coming back at you.
    6. CVS Caremark may have issued "gag clauses" (Need to confirm that but likely.)
    7. CVS Caremark restricted drug choice to the detriment of optimal therapeutic care
    8. Derica W. Rice helped drive in his legacy, to be spoken at his unedited eulogy, a WIDER health care gap between poorer AMERICANS and wealthy communities (i.e. Where Derica W. Rice lavishly resides in his noble suffering for a greater cause).
    Bottom Line for the accountant extraordinaire, former PRESIDENT of CVS Caremark?
    Derica W. Rice has adversely affected the health care of millions of U.S. citizens; the pharmacists who serve them; and the U.S. States they all reside in rural, inner city and underserved areas for profit.

    ~Now there is a NEW BMS SOCIAL AGENDA to emulate!~
     
  11. anonymous

    anonymous Guest

    WHO DO YOU WORK FOR? WHAT INDUSTRY IS THIS? WHO DO WE SAY WE SERVE WITH OUR LIPS?
    WHAT IS OUR MISSION STATEMENT? WHAT VISION DO YOU HAVE FOR THIS COUNTRY, YOUR STATE, YOUR COMMUNITY, FAMILY AND FRIENDS if any?


    This is NOVEMBER 2020, Mr. Orwell. Some of us still have a sense of dignity, pride, moral ethos here at Bristol-Myers Squibb to not blindly follow. Neither will State AGs who know wrong when it is right in front of you. That is Derica W. Rice's full, unadulterated eulogy upon passing from a "free" land with a free voice.

    Big-time PBM scrutiny on the way as U.S. Supreme Court agrees to hear Arkansas case

    Oral arguments in U.S. Supreme Court PBM case get a new date

    Supreme Court hears drug benefits case with wide-ranging impact

    US Supreme Court Proceeds With Hearing on Landmark PBM Regulation Case
     
  12. anonymous

    anonymous Guest

    Here is as "short list" of what this U.S. citizen, Derica W. Rice, our newly elected Board Member, did leading CVS Caremark as their President to other U.S. citizens. Things he led as President of said organization in pursuit of competitive dominance, wealth and ultimately, health care power over people, the pharmacy profession and States:

    Bottom Line for the accountant extraordinaire, former PRESIDENT of CVS Caremark?
    Derica W. Rice has adversely affected the health care of millions of U.S. citizens; the pharmacists who serve them; and the U.S. States they all reside in rural, inner city and underserved areas for profit.

    [/QUOTE]

    Bristol Myers Squibb
    COMMITMENT

    To our patients and customers
    Excerpted,
    We actively seek to improve access to care, advocate for policies that promote health equity, and help underserved patients access and afford the medicines they need.

    So, Derica W. Rice's record, his legacy, appears to speak loudly in direct opposition to that BMS Commitment we pursue each day. Literally tens of thousands of underserved patients have been adversely affected by how CVS Caremark has been led.
    Most of us make a sincere commitment to our patients, those customers we serve each day in health care. As health care professionals, scientists, manufacturing, sales and marketing, operations and everyone helping us honor that commitment.

    So, why would anyone with integrity pick up the phone and call this person? A serious dialogue regarding our Board of Directors, expanded format from twelve to fourteen? And then have this individual brought forward and voted upon during this past, troubled summer?

    Essentially, saying (fiction of course),
    "Mr. recent past President, CVS Caremark, you may have one of these Board seats, if you'd like. You have the accounting expertise as former, Lilly finance guru and leader. You have the current, full inside knowledge of how PBMs like CVS Caremark run it's business and profit. More importantly, you know what directions it's going and how to network and negotiate through PBM change. But that's not why we want you."
    "No?"
    "It's because your not a perfectionist. You openly admit your mistakes in life to grow professionally and personally. You make yourself vulnerable to scrutiny. Your willing to sacrifice to your own detriment for others. You are noble beyond reproach as you have given all possessions away to follow a higher calling and cause to serve others in healthcare need."
    "Really?"
    "Yes, Derica, you remind me a lot of others here, including a bit like me. You are one of us, not them."
    "With all due respect, Giovanni, I already knew that."
    "See you this Fall, bud. And a quick reminder, Derica,...mind your manners as I know you will. Chao."

    Going back to E.R. Squibb days, "the priceless ingredient of every product is the (honor) and integrity of the maker." Well everyone, here at Bristol-Myers Squibb. Our executive leadership is failing in the "honor" dropped from this marketing phrase. Integrity is hanging by it's finger tips.

    This lacks transparency. Lacks judgement. It lacks honest forthrightness. All of the 'animal deals' behavior repeated over and over by CVS Caremark are well known. Fully documented. We live it every day. Most of us watching, expected the U.S. Supreme Court would likely hear this PBM case. This Board selection was extremely important. Yet, apparently made this turbulent spring and summer for reasons painfully counter to what Bristol Myers Squibb nobly....aspires. Diverse leadership that demonstrates a clear, full commitment to our mission and commitments to all stakeholders, especially those patients and customers we serve.

    Board of Directors at Bristol Myers Squibb
    Great Print Advertising: SQUIBB - "The Priceless Ingredient"
     
  13. anonymous

    anonymous Guest

    Bristol Myers Squibb
    COMMITMENT

    To our patients and customers
    Excerpted,
    We actively seek to improve access to care, advocate for policies that promote health equity, and help underserved patients access and afford the medicines they need.

    So, Derica W. Rice's record, his legacy, appears to speak loudly in direct opposition to that BMS Commitment we pursue each day. Literally tens of thousands of underserved patients have been adversely affected by how CVS Caremark has been led.
    Most of us make a sincere commitment to our patients, those customers we serve each day in health care. As health care professionals, scientists, manufacturing, sales and marketing, operations and everyone helping us honor that commitment.

    This Board selection was extremely important. Yet, apparently made this turbulent spring and summer for reasons painfully counter to what Bristol Myers Squibb nobly....aspires. Diverse leadership that demonstrates a clear, full commitment to our mission and commitments to all stakeholders, especially those patients and customers we serve.
    [/QUOTE]
    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    A section of the recent Ohio Pharmacist Association - You know, fellow Bristol Myers Squibb professionals, an association of medical PROFESSIONALS in a given state we do business that play an active, central role in their healthcare profession without applying convoluted "accounting skills" focused principally on corporate dominance, power, leverage and massive financial gain. But rather, these folks fundamentally DO take care of PATIENTS in their state, nobly. And, if anyone wants to see the State of Ohio MEDICAID PBM Audit, it's all there in currency GREEN and RED ink RED, depending on which side of the noble cause your on.

    November 13, 2020
    Ohio Auditor releases stunning Medicaid PBM audit report
    Today, Ohio Auditor Dave Yost, in a presentation to the Joint Medicaid Oversight Committee, released the results of his audit of the Ohio Medicaid prescription drug program. To be blunt, the results are jaw-dropping. (Is your jaw dropping Derica? How about your jaw, Giovanni, person of highest integrity?)

    While we are still digesting the full 33-page report, it is abundantly clear that reform is needed for a myriad of reasons. The report highlights some deeply troubling issues not just for pharmacists, but taxpayers and patients as well. Check out the report on today's events from the Columbus Dispatch's Marty Schladen HERE.

    "What we see in this report are the truly unfathomable lengths that these massive corporate middlemen will go to manipulate the prescription drug marketplace and hide their litany of revenue streams," said OPA government affairs director Antonio Ciaccia. "It is now overwhelmingly apparent that PBMs are operating the biggest shell game in modern history, and we are all paying for it."

    "Today, we learned that at a fundamental level, we as taxpayers have been paying more for less," said OPA Executive Director Ernie Boyd. "But we know that Ohio is not alone. Every state and every payer in the country is grappling with these overinflated costs. The good news is that Governor Kasich and Ohio Medicaid are leading the way on the transparency necessary for true spending reform."

    This NEVER would have happened, the uncovering of these massive PBM accounting manipulations that under paid pharmacists in inner cities and underserved areas and over charged states, if it were not for some truly NOBLE healthcare professionals who saw what companies like CVS Caremark, led by Derica W. Rice, President were doing. It NEVER would of stopped because people running companies like CVS Health/CVS Caremark lack HONESTY, lack COURAGE, lack HUMILITY, lack apparent GUILT and certainly, NO SHAME for their business behavior that enriches themselves in the U.S. healthcare system. They lack the INTEGRITY our BMS executive team has stressed as part of who we are in all things. Do you see that this Board appointment has unequivocally violated our Bristol Myers Squibb's highest principled Commitment to Patients and Customers we serve? Which person are you, Nov. 17, 2020?

    ~This is a substantial part of Derica W. Rice's complete, unadulterated eulogy upon passing from a free land with a free voice to speak the whole truth and nothing but the truth, so help you God.~
     
  14. anonymous

    anonymous Guest

    If you or I did anything remotely like what CVS Caremark executive leadership has done the last several years in this country, you'd either land on the street, potentially with a record or at least cancelled from ever working in pharmaceuticals again... or maybe, just maybe you'd jump onto the executive team's short list. It'd all depend on who saw what, when, who benefited or was placed 'at risk'? Integrity is dead last as the filter for such apparent egregious behaviors, Nov. 18, 2020.

    ~ Derica W. Rice's eulogy will include major decisions he ultimately, made or approved adversely affecting underserved patients who live in inner cities and rural areas of the United States of America. These decisions are unequivocally, diametrically opposed to Bristol Myers Squibb's highest Commitment to healthcare equity and underserved patient populations we serve with our products.~
     
  15. anonymous

    anonymous Guest

    What a looneybin, lol!
     
  16. anonymous

    anonymous Guest

    Love thread.

    Pits corporate greed of any executive color against the least of us
     
  17. anonymous

    anonymous Guest

    As we approach Thanksgiving in a country where as many as 1 in 10 will not have enough to eat that day or any day, maybe we should better understand our bed fellows and unchallenged leadership?

    Maybe we should have enough courage and integrity to vehemently object to a recent Board member addition decisions? A Board leadership that has demonstrated by this decision to add a member who has 'apparently' acted in their recent career in clear, diametrically opposed manner to Bristol Myers Squibb's stated Commitment. A Commitment to health equity and affordable access for the underserved patients and customers in these United States of America.

    If you care, read the actual Supreme Court docket submission from Arkansas and 44 OTHER STATES as well as the District of Columbia below. Integrity matters in all things, not just exploitable political ones.

    https://www.supremecourt.gov/DocketPDF/18/18-540/134605/20200302130544620_18-540tsacCalifornia.pdf


    Bristol Myers Squibb COMMITMENT to Patients and Customers
    We actively seek to improve access to care, advocate for policies that promote health equity, and help underserved patients access and afford the medicines they need.
     
  18. anonymous

    anonymous Guest

    Derica W. Rice, your legacy reads at your eulogy, "Mr. Derica W. Rice played a major, leading role in adversely affecting millions of underserved patients in inner cities and rural communities while over charging virtually every state in the Union for profit and business gain. He condoned and facilitated the underpaying of community pharmacies and pharmacists who nobly serve those underserved patients and their families by untold millions. Thus creating 'pharmacy deserts' in areas all over the United States of America for his power grab at CVS Caremark and unjust profit."

    If you care, read the actual Supreme Court docket submission from Arkansas and 44 OTHER STATES as well as the District of Columbia below.

    https://www.supremecourt.gov/DocketPDF/18/18-540/134605/20200302130544620_18-540tsacCalifornia.pdf

    Integrity matters in all things, not just exploitable political ones.


    The loudest and most powerful should not trample on the least.

    If you do trample on the least, you are a hypocrite of the highest order in health care yielding no respect, no nobility and no integrity.


    Bristol Myers Squibb COMMITMENT to Patients and Customers
    We actively seek to improve access to care, advocate for policies that promote health equity, and help underserved patients access and afford the medicines they need. [/QUOTE]

    Analysis Blows Lid Off $8.5 Billion PBM Scam, Says Community Pharmacy
    February 12, 2020 15:31 ET | Source: National Community Pharmacists Association
    Alexandria, Va., Feb. 12, 2020

    It should be shocking to state and federal lawmakers and regulators that pharmacy benefit manager corporations are using a government loophole to squeeze billions of dollars in fees from pharmacies, that those fees are driving up the cost of prescription drugs for patients, and that the sickest people in the country are subsidizing insurance premiums,” said B. Douglas Hoey, pharmacist, MBA, NCPA CEO.

    The analysis, released yesterday by XIL Consulting, who advises some of the top players in the industry, concludes that pharmacy benefit managers are making enormous profits on so-called direct and indirect remuneration fees. PBMs impose the fees on pharmacies on a per-prescription basis. They’re assessed after – sometimes months after - the point of sale.

    “DIR pharmacy fees overall have skyrocketed by 1,600% in the last five years, totaling $8.5B since 2013,” says the report. According to the firm, “a loophole in the program allows health plans and PBMs to pocket an excessive amount of pharmacy DIR fees rather than offset prescription costs for seniors.”
     
  19. anonymous

    anonymous Guest

    Shocking that BMS could actually make a mistake.

    Call in the clowns!
     
  20. anonymous

    anonymous Guest

    Derica W. Rice, your legacy reads at your eulogy, "Mr. Derica W. Rice played a major, leading role in adversely affecting millions of underserved patients in inner cities and rural communities while over charging virtually every state in the Union for profit and business gain. He condoned and facilitated the underpaying of community pharmacies and pharmacists who nobly serve those underserved patients and their families by untold millions. Thus creating 'pharmacy deserts' in areas all over the United States of America for his power grab at CVS Caremark and unjust profit."

    You forgot the part, 'where he gave X thousand dollars of his ill gotten wealth in a health care JOB, strapped on the backs of inner city, rural and underserved populations across the United States of America to charities. Charities or interests of his choice that essentially held him up in false esteem so he was able to sleep at night and strut in demi-god fashion across this free land he freely transgressed without impunity in this lifetime.'

    Thus far, Derica, thus far my ill fit Bristol-Myers Squibb newest Board Member.

    To our patients and customers
    We commit to scientific excellence and investment in biopharmaceutical research and development to provide innovative, high-quality medicines that address the unmet medical needs of patients with serious diseases. We apply scientific rigor to produce clinical and economic benefit through medicines that improve patients’ lives. We strive to make information about our commercialized medicines widely and readily available. We actively seek to improve access to care, advocate for policies that promote health equity, and help underserved patients access and afford the medicines they need.